Clinical Trial Update: Minocycline as Neuroprotectant After Aneurysmal Subarachnoid Hemorrhage [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial evaluating minocycline as a neuroprotectant after aneurysmal subarachnoid hemorrhage has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Subarachnoid Hemorrhage

Drugs mentioned

• Minocycline (minocycline)

Snippet

Sponsor: University at Buffalo | Conditions: Subarachnoid Aneurysm Hemorrhage | Phase 1, Phase 2 | Status: WITHDRAWN